INCIDENCE OF NEUROPATHY IN PATIENTS TREATED WITH SUBCUTANEOUS BORTEZOMIB

被引：0
|
作者：
Vicent Castello, A. [1 ]
Pellise Guinjoan, A. [2 ]
Escoda Teigell, L. [1 ]
Casanova Molla, J. [2 ]
Pascual Rubio, V [2 ]
Talarn Forcadell, C. [1 ]
Do Nascimento, J. [1 ]
Vallansot, R. [1 ]
Aguinaco Culebras, R. [1 ]
Gimenez Perez, T. [1 ]
Araguas Arasanz, C. [1 ]
Bru Orobal, N. [1 ]
Esteban Figuerola, A. [1 ]
Sarra Escarre, J. [1 ]
机构：
[1] ICO Tarragona, Tarragona, Spain
[2] Hosp Univ Joan XXIII Tarragona, Tarragona, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-092
引用
收藏
页码：113 / 114
页数：2
相关论文
共 50 条
  • [41] Neuropathic pain in cancer patients treated with bortezomib
    Exposito Vizcaino, S.
    Casanova-Molla, J.
    Escoda, L.
    Galan, S.
    Miro, J.
    NEUROLOGIA, 2018, 33 (01): : 28 - 34
  • [42] Unexpected cardiotoxicity in haematological bortezomib treated patients
    Orciuolo, Enrico
    Buda, Gabriele
    Cecconi, Nadia
    Galimberti, Sara
    Versari, Daniele
    Cervetti, Giulia
    Salvetti, Antonio
    Petrini, Mario
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (03) : 396 - 397
  • [43] The course of chemotherapy-induced peripheral neuropathy (CIPN) in hematological patients treated with vincristine, bortezomib, or lenalidomide: the NOVIT study
    Maksten, Eva Futtrup
    Morch, Carsten Dahl
    Jakobsen, Lasse Hjort
    Kragholm, Kristian Hay
    Blindum, Pernille From
    Simonsen, Mikkel Runason
    Ejskjaer, Niels
    Dybkaer, Karen
    Gregersen, Henrik
    Madsen, Jakob
    El-Galaly, Tarec C.
    Severinsen, Marianne Tang
    SUPPORTIVE CARE IN CANCER, 2025, 33 (03)
  • [44] Subcutaneous Bortezomib In Multiple Myeloma
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (01) : 45 - 54
  • [45] New Data on Subcutaneous Bortezomib
    Moreau, Philippe
    Touzeau, Cyrille
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 26 - 28
  • [46] Peripheral neuropathy outcomes and efficacy of subcutaneous bortezomib when combined with thalidomide and dexamethasone in the treatment of multiple myeloma
    Liu, Hong
    Xu, Ruirong
    Huang, Hongming
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (05) : 3041 - 3046
  • [47] Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Pezzi, Annalisa
    Rocchi, Serena
    Cavo, Michele
    HAEMATOLOGICA, 2014, 99 (11)
  • [48] INCIDENCE OF AUTONOMIC NEUROPATHY AMONG PATIENTS WITH SMALL FIBER NEUROPATHY
    Lagattuta, Francis
    Tipei, Cristina
    Tipei, James
    Lagattuta, Lane
    Tian, Austin
    MUSCLE & NERVE, 2019, 60 : S110 - S110
  • [49] Incidence and relative risk of peripheral neuropathy in cancer patients treated with eribulin: a meta-analysis
    Peng, Ling
    Hong, Yun
    Ye, Xianghua
    Shi, Peng
    Zhang, Junyan
    Wang, Yina
    Zhao, Qiong
    ONCOTARGET, 2017, 8 (67) : 112076 - 112084
  • [50] INCIDENCE AND RISK FACTORS OF ACUTE KIDNEY INJURY AND TUMOR LYSIS SYNDROME IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH BORTEZOMIB
    Song, Seungmin
    Boo, Hyo Jin
    Jang, Hye Ryoun
    Huh, Wooseong
    Kim, Dae Joong
    Kim, Yoon-Goo
    Lee, Jung Eun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 888 - 888
12345